Children obesity and its metabolic outcomes
Authors:
Zlatko Marinov 1; Dalibor Pastucha 2
Authors‘ workplace:
FN Motol a 2. LF UK, Dětská poliklinika, Dětská obezitologická ambulance, Praha
1; Fakultní nemocnice Olomouc, Klinika tělovýchovného lékařství a kardiovaskulární rehabilitace
2
Published in:
Čas. Lék. čes. 2012; 151: 135-140
Category:
Review Articles
Overview
According to current statistics, there are, at an average child’s general practice about seventy children registered with obesity, including fifty children indicated for long-term treatment of obesity due to medical indications, fifteen children are intended for targeted modifications in their diet, and in almost every practice there is a child with a pathognomonic obesity. Currently, we are exposed to food-borne pandemic coupled polygenic obesity, which is a chronic metabolic disease with societal consequences. Alimentary obesity mainly reflects an early onset of cardio-metabolic risk, but the clinical picture of complications of childhood obesity is broader and includes not only the risk of life-limitation, but also respiratory, gastrointestinal, neurological, orthopaedic and endocrine complications along with serious psychosocial problems. The effects caused by childhood obesity are reversible initially, and early identification and treatment is a major clinical challenge in preventing the development of serious metabolic, organ, psychological and societal complications.
Key words:
obesity in children, cardio-metabolic risk, metabolic syndrome, liver steatosis, obstructive sleep apnea syndrome.
Sources
1. Vignerová J, Riedlová J, Bláha P, et al. 6. celostátní antropologický výzkum dětí a mládeže 2001. Česká republika. Souhrnné výsledky. PřF UK. Praha: SZÚ 2006; 238.
2. Marinov Z. Praktická dětská obezitologie. Praha: Grada Publishing 2012.
3. Ludwig DS. Childshood obesity – the shape of things to come. N Engl J Med 2007; 7(23): 2325–2327.
4. Lobstein T., Jackson-Leach R. Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. Int J Pediatr Obes 2006; 1(1): 33–41.
5. Krásničanová H. Vztahy mezi tělesnou hmotností a skeltální a sexuální maturací. Stav výživy a biologický věk – vybrané auxologické aspekty. Postgraduální medicína 2010; 2(Suppl): 52–60.
6. Franks PW, Hanson RL, Knowler WC, et al. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med. 2010; 362(6): 485–493.
7. Dam RM, Willett WC, Manson JE, Hu FB. The relationship between overweight in adolescence and premature death in women. Ann Intern Med 2006; 145(2): 91–97.
8. Avenell A, Broom J, Brown TJ, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004; 8(21): 1–182.
9. Christakis NA, Fowler JH. The spread of obesity in a large social network over 32 years. N Engl J Med 2007; 357(4): 370–379.
10. Hillier TA, Pedula KL, Schmidt MM, et al. Childhood obesity and metabolic imprinting. Diabetes Care 2007; 30(9): 2287–2292.
11. Franks PW, Ling C. Epigenetics and obesity: the devil is in the details. BMC Med 2010; 21(8): 88.
12. Ramachandrappa S, Farooqi IS. Genetic approaches to understanding human obesity. J Clin Invest 2011; 121(6): 2080–2086.
13. Dabelea D, Crume T. Maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 2011; 60(7): 1849–1855.
14. Pastucha D, Malinčíková J, Číhalík Č, et al. Obesity, hypertension and insulin resistance in childhood. Acta Medica Martinina. 2008; 8(1): 17–22.
15. Nobili V, Alisi A, Raponi M. Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol. 2009; 15(48): 6017–6022.
16. Kohler MJ, Thormaehlen S, Kennedy JD, et al. Differences in the association between obesity and obstructive sleep apnea among children and adolescents. J Clin Sleep Med 2009; 5(6): 506–511.
17. Horakova D, Stejskal D, Pastucha D, et al. Potential markers of insuline resistance in healthy vs obese and overweight subjects. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010; 154(3): 245–250.
18. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348(17): 1625–1638.
19. Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am j Clin Nutr 2006; 83: 1237–1247.
20. Zimmet P, Alberti KG, Kaufman F, et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007; 8(5): 299–306.
21. Simmons RK, Alberti KG, Gale EA, Colagiuri S, et al. The metabolic syndrome: useful concept or clinical tool? Diabetologia 2010; 53(4): 600–605.
22. Pastucha, D., Hyjánek, J., Horáková, D. Hypertenze dětského věku a její vztah k inzulinové rezistenci. Pediatrie pro praxi 2007; 8: 237–239.
23. Haffner SM, Miettinen H, Stern MP. The homeostasis model in the San Antonio heart study. Diabetes Care. 1997; 20: 1087–1092.
24. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402–2410.
25. Pastucha D, Talafa V, Malincikova J, et al. Obesity, hypertension and insulin resistance in Childhood – a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010; 154(1): 77–82.
26. Steinberger J, Daniels SR, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents. Circulation 2009; 119(4): 628–647.
27. Marinov Z, Čepová J. Metabolické parametry pacientů dětské obezitologické ambulance. Čs Pediatrie 2010; 2: 72–78.
28. Vitáriušová E, Košťálová Ľ, Pribilincová Z, et al. Výskyt metabolického syndrómu a jeho komponentov u obéznych detí. Čs Pediatrie 2010; 2: 55–61.
29. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol 2010; 26: 5–11.
30. Musso G, Gambino R, Cassader M. Obesity, Diabetes, and Gut Microbiota. Diabetes Care 2010; 33: 2277–2284.
31. Nobili V, Alisi A, Raponi M. Pediatric non-alcoholic fatty liver disease: preventive and therapeutic value of lifestyle intervention. World J Gastroenterol 2009; 15(48): 6017–6022.
32. Chan DF, Li AM, Chu WC, et al. Hepatic steatosis in obese Chinese children. Int J Obes Rel et Metab Disord 2004; 28(10): 1257–1263.
33. Kohler MJ, Thormaehlen S, Kennedy JD, et al. Differences in the association between obesity and obstructive sleep apnea among children and adolescents. J Clin Sleep Med 2009; 5(6): 506–511.
34. Rodriguez MA, Winkleby MA, Ahn D, et al. Identification of population subgroups of children and adolescents with high asthma prevalence: findings from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med 2002; 156(3): 269–275.
35. Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA 2003; 289(2): 187–193.
36. Marinov Z, Barčáková U, Nesrstová M, Pastucha D. S dětmi proti obezitě. Praha: IFP publishing 2011.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- Autophagy and its role in protective and damaging inflammatory response
- Children obesity and its metabolic outcomes
- Thyroid tumors – moleculargenetic causes and choices for target therapy
- Factors influencing the experimentation with smoking: Observed in ELSPAC Study